The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced gastroesophageal junction cancer (GEJC) and esophageal adenocarcinoma (EAC): Analysis of KEYNOTE-590 and KEYNOTE-859 by tumor type.
 
Zev A. Wainberg
Consulting or Advisory Role - Alligator Bioscience; Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Ipsen; Lilly; Merck; Merck KGaA; Novartis; Pfizer; PureTech; Seagen
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck
 
Kai-Keen Shiu
Honoraria - Daiichi Sankyo Europe GmbH; Innovent Biologics; Merck Serono; MSD Oncology; SERVIER
Consulting or Advisory Role - Mirati Therapeutics; MSD Oncology; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
(OPTIONAL) Uncompensated Relationships - MSD Oncology
 
Fernando Rivera
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Roche; Sanofi/Aventis; SERVIER
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Roche; Sanofi/Aventis; SERVIER
Research Funding - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Serono; MSD; Roche (Inst); Sanofi/Aventis; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; MSD; Roche; SERVIER
Other Relationship - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Roche; Sanofi/Aventis; SERVIER
 
Louise C. Medley
No Relationships to Disclose
 
Morteza Aghmesheh
No Relationships to Disclose
 
Richard Francis Dunne
Consulting or Advisory Role - Exelixis; Helsinn Therapeutics; Merck; Toray Industries Inc.
 
Rajarshi Roy
Honoraria - Bristol-Myers Squibb; Servier
Consulting or Advisory Role - Bristol-Myers Squibb; Servier
Speakers' Bureau - Bristol-Myers Squibb; SERVIER
Travel, Accommodations, Expenses - Servier
 
Lucjan S. Wyrwicz
Honoraria - BeiGene; BMS; MSD
Consulting or Advisory Role - GlaxoSmithKline; SERVIER
Speakers' Bureau - BMS
Travel, Accommodations, Expenses - SERVIER
 
Timothy Larson
Employment - Minnesota Oncology
 
Jean-Philippe Metges
Honoraria - Bayer; Bristol-Myers Squibb; MSD
 
Wasat Mansoor
Honoraria - Bristol-Myers Squibb; Servier
Consulting or Advisory Role - Bristol-Myers Squibb; Servier
Speakers' Bureau - Bristol-Myers Squibb; Servier
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; MSD Oncology; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - SERVIER
 
Luiz Carlos Moreira Antunes
No Relationships to Disclose
 
Victor Castro Oliden
No Relationships to Disclose
 
Erin Jensen
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sukrut Shah
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sonal Bordia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Pooja Bhagia
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Maeve Aine Lowery
Consulting or Advisory Role - AstraZeneca; Roche/Genentech; SERVIER
Research Funding - Astellas Pharma; Basilea; Exelixis; MSD